Capital Expenditures for Zoetis (ZTS)
According to Zoetis's latest reported financial statements, the company's current capital expenditures (TTM) is $621.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

ZTS
Currently viewingCapital ExpendituresSwitch metric
Latest period
$621.00M
YoY change
-5.2%
5Y CAGR
+6.5%
Peak year (2023)
$732.00M
Cumulative capital expenditures
$5.88B
CapEx history chart for Zoetis (ZTS) from 2009 to 2025
CapEx history table for Zoetis (ZTS) from 2009 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $621.00M | -5.2% | ||
| 2024 | $655.00M | -10.5% | ||
| 2023 | $732.00M | +24.9% | ||
| 2022 | $586.00M | +22.9% | ||
| 2021 | $477.00M | +5.3% | ||
| 2020 | $453.00M | -1.5% | ||
| 2019 | $460.00M | +36.1% | ||
| 2018 | $338.00M | +50.9% | ||
| 2017 | $224.00M | +3.7% | ||
| 2016 | $216.00M | -3.6% | ||
| 2015 | $224.00M | +14.9% | ||
| 2014 | $195.00M | +6.0% | ||
| 2013 | $184.00M | +46.0% | ||
| 2012 | $126.00M | -6.7% | ||
| 2011 | $135.00M | +8.9% | ||
| 2010 | $124.00M | -8.1% | ||
| 2009 | $135.00M | — |
CapEx values are taken from Zoetis's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Zoetis (ZTS) most recent annual capital expenditures stands at $621.00M (2025) – declined 5.2% year-over-year.
Over 2020–2025 (5 years), Zoetis capital expenditures expanded at a +6.5% compound annual rate, with the latest reading among the more recent periods of the dataset.
Zoetis capital expenditures peaked at $732.00M in 2023; the latest annual figure is $621.00M in 2025 (15.2% below peak).
Across the available history, capital expenditures reached its high of $732.00M in 2023 and its low of $124.00M in 2010.
Zoetis (ZTS) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Zoetis Capital Expenditures by Year
Zoetis Capital Expenditures 2025: $621.00M
Zoetis capital expenditures in 2025 was $621.00M, declined 5.2% below 2024.
Zoetis Capital Expenditures 2024: $655.00M
Zoetis capital expenditures in 2024 was $655.00M, declined 10.5% below 2023.
Zoetis Capital Expenditures 2023: $732.00M
Zoetis capital expenditures in 2023 was $732.00M, grew 24.9% from 2022. This figure represents the highest annual value in the available history.
Zoetis Capital Expenditures 2022: $586.00M
Zoetis capital expenditures in 2022 was $586.00M, grew 22.9% from 2021.
Zoetis Capital Expenditures 2021: $477.00M
Zoetis capital expenditures in 2021 was $477.00M.
See more financial history for Zoetis (ZTS).
Sector peers — CapEx
Companies in the same sector as Zoetis, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Zoetis's capital expenditures?
- Latest reported capital expenditures for Zoetis (ZTS) is $621.00M (period ending December 31, 2025).
How has Zoetis capital expenditures changed year-over-year?
- Zoetis (ZTS) capital expenditures changed -5.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Zoetis capital expenditures?
- Zoetis (ZTS) capital expenditures compound annual growth rate is +6.5% over the most recent 5 years available.
When did Zoetis capital expenditures hit its highest annual value?
- Zoetis capital expenditures reached its highest annual value of $732.00M in 2023.
What was Zoetis capital expenditures in 2024?
- Zoetis (ZTS) capital expenditures in 2024 was $655.00M.
What was Zoetis capital expenditures in 2025?
- Zoetis (ZTS) capital expenditures in 2025 was $621.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ZTS Overview
Company profile, financial tools, and key metrics
ZTS Revenue Counter
Earns $300.20 every second. See per minute, hour, and day.
ZTS Earnings Counter
Earns $84.76 per second net profit. See per minute, hour, and day.
ZTS Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
ZTS What If Invested
What if you had invested $1,000? See historical returns from any date.
ZTS How It Makes Money
Discover visual breakdown of $9.47B in revenue — where it comes from and where it goes.
ZTS Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ZTS Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ZTS Daily Price Character
Steady · 51.8% historical win rate (green days). Streaks & record days.
ZTS Buybacks
5.87% TTM buyback yield. Shareholder yield & SBC comparison.
ZTS Dividend Profile
Yield: 1.81%. Safety: 7/8. See full history.
ZTS Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ZTS Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.